Musician and writer Tony Bellotto, 66, was hospitalized in Rio de Janeiro after experiencing a medical complication. The Titãs guitarist, who was diagnosed with pancreatic cancer in March 2025, had to step away from professional commitments on medical advice. The band announced the hospitalization on social media last Friday, Nov. 6.
According to information reported by Folha de S.Paulo, Bellotto did not attend the keynote lecture he was scheduled to give at the Brazilian Society of Clinical Oncology congress, which took place Friday. He was also absent from a Titãs concert scheduled for Saturday, Nov. 7, in São José dos Campos, in the state of São Paulo. The show went ahead with the other members of the band.
Oncologist Fernanda Caparelli, who is responsible for Bellotto’s medical care, attended the congress in his place. Caparelli said the musician was doing well but needed to remain hospitalized for observation, following the guidance of the team overseeing his treatment. The band and the medical professionals did not disclose the nature of the complication that led to his admission.
The information released about the hospitalization does not specify how long Bellotto is expected to remain in the hospital or when he might resume his professional activities. It also does not describe a change to his cancer treatment. The stated reason for his absence from the lecture and concert was the medical recommendation that he temporarily withdraw from commitments while under observation.
Bellotto has been undergoing treatment for pancreatic cancer since March 2025. In April of that year, about a month after receiving the diagnosis, he had surgery to remove the tumor. He then began chemotherapy sessions intended to address possible microscopic cancer cells that could remain after surgery. The account of his treatment does not provide further details about the procedure, the chemotherapy regimen or the results of subsequent medical evaluations.
He was discharged from the hospital at the end of April 2025 and later returned to professional activities while continuing periodic medical follow-up. His latest hospitalization, in Rio de Janeiro, came after that return to work. The available information does not say whether the new clinical complication was related to his cancer, his prior surgery or his ongoing treatment, and no connection should be assumed from the announcement alone.
Two days before the hospitalization was made public, on Wednesday, Nov. 4, Bellotto spoke to Folha de S.Paulo about changes in his routine since learning he had cancer. In audio messages sent to the newspaper, he reflected on the way he had come to view everyday life during treatment. “Each day I wake up is more special than it was before the diagnosis,” he said.
In the same interview, Bellotto described his attitude toward the illness with a line by Brazilian poet Paulo Leminski: “I don’t argue with fate; whatever comes, I sign.” The remark was part of his account of how the diagnosis had affected his outlook. It did not provide medical information about his condition or treatment.
The congress he was scheduled to address brings together professionals in clinical oncology, the field concerned with the medical treatment of cancer. Bellotto’s lecture was described as a keynote session, but the information published about the event does not include its planned subject or the details of what he intended to discuss. Caparelli’s participation in his place allowed the congress appearance to proceed without him, while he remained hospitalized.
Pancreatic cancer is a disease involving abnormal cell growth in the pancreas, an organ in the abdomen that has roles in digestion and in regulating blood sugar. Treatment decisions for an individual patient depend on medical evaluations and factors specific to that person. Surgery and chemotherapy are among the treatment approaches used in cancer care, but the mention of those treatments in Bellotto’s case does not establish what his doctors may recommend next or what his prognosis is.
In general, observation in a hospital allows a medical team to monitor a patient and assess a clinical concern. The fact that Bellotto was kept for observation, as reported by his oncologist, does not by itself identify the cause or seriousness of the event. The band did not release details about symptoms, test results or the expected length of his stay. The public information remained limited to his hospitalization, the recommendation to pause work and the doctor’s statement that he was doing well while needing continued observation.
The two missed commitments were different in nature: one was a professional appearance at an oncology congress, and the other was a live performance with Titãs. The band’s concert in São José dos Campos continued with the other members, while Bellotto stayed away on medical advice. No further information was given about changes to the group’s upcoming schedule.
Bellotto is known as a guitarist for Titãs and also works as a writer. His earlier return to professional activities after his April 2025 discharge took place while he continued medical follow-up, according to the account published about his treatment. The new announcement indicates that he has again temporarily suspended commitments, but it does not say whether the interruption will extend beyond the events scheduled for Nov. 6 and 7.
The timeline publicly described begins with the cancer diagnosis in March 2025, followed by surgery the next month and chemotherapy afterward. Bellotto was discharged at the end of April 2025 and resumed work while remaining under medical care. In November 2026, he was hospitalized in Rio de Janeiro after an unspecified clinical complication. The band’s announcement and Caparelli’s comments supplied no additional clinical details.
For now, the reported information centers on the immediate changes to his schedule and the fact that he remained under medical supervision. Bellotto missed his congress lecture and the Titãs concert, and his oncologist attended the congress in his place. His medical team’s guidance was that he stay in the hospital for observation. No further update about his condition, discharge or return to work was included in the information provided.
